
|Videos|September 16, 2016
How High Cost Oncology Drugs Are Changing Specialty Pharmacy
Author(s)Lauren Santye, Assistant Editor
Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses the impact of oncology medications and how specialty pharmacies can adjust.
Advertisement
Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses the impact of oncology medications and how specialty pharmacies can adjust.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Should Know About High-Dose Semaglutide’s Safety Profile
2
Polycystic Ovary Syndrome Undergoes Name Change: Polyendocrine Metabolic Ovarian Syndrome
3
GLP-1 Receptor Agonists Linked to Improved Survival Outcomes in Breast Cancer
4
A First-of-Its-Kind All-Oral Option Receives FDA Approval for Newly Diagnosed AML
5

































































































































